Stock chart
Ticker: EXAS Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-13 2024-11-13 B Purchase

Conroy Kevin T

President and CEO

Executive Director
19,500 +1.8%
51.35
USD 1,001,325
19,500 +1.8% 51.35 USD 1,001,325
2024-10-09 2024-10-08 PS Planned sale

Baranick Brian

EVP, GM, Precision Oncology

Officer
929 -6.8%
70.00
USD 65,030
929 -6.8% 70.00 USD 65,030
2024-09-19 2024-09-18 PS Planned sale

Baranick Brian

EVP, GM, Precision Oncology

Officer
929 -6.4%
70.00
USD 65,030
929 -6.4% 70.00 USD 65,030
2024-05-02 2024-05-01 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
1,155 -0.1%
60.15
USD 69,473
1,155 -0.1% 60.15 USD 69,473
2024-05-02 2024-05-01 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
1,155 -0.1%
60.15
USD 69,473
1,155 -0.1% 60.15 USD 69,473
2024-05-02 2024-05-01 PS Planned sale

Baranick Brian

EVP, GM., Precision Oncology

Officer
110 -0.8%
60.15
USD 6,617
110 -0.8% 60.15 USD 6,617
2024-05-02 2024-05-01 PS Planned sale

Baranick Brian

EVP, GM., Precision Oncology

Officer
110 -0.8%
60.15
USD 6,617
110 -0.8% 60.15 USD 6,617
2024-05-02 2024-05-01 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
102 -0.7%
60.15
USD 6,135
102 -0.7% 60.15 USD 6,135
2024-05-02 2024-05-01 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
102 -0.7%
60.15
USD 6,135
102 -0.7% 60.15 USD 6,135
2024-05-02 2024-05-01 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
136 -1.1%
60.15
USD 8,180
136 -1.1% 60.15 USD 8,180
2024-05-02 2024-05-01 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
136 -1.1%
60.15
USD 8,180
136 -1.1% 60.15 USD 8,180
2024-05-02 2024-05-01 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
102 -0.1%
60.15
USD 6,135
102 -0.1% 60.15 USD 6,135
2024-05-02 2024-05-01 PS Planned sale

COWARD D SCOTT

Non-Executive Director
67 -0.1%
60.15
USD 4,030
67 -0.1% 60.15 USD 4,030
2024-05-02 2024-05-01 PS Planned sale

Herriott James

SVP, General Counsel & Sec

Officer
30 -0.3%
60.15
USD 1,805
30 -0.3% 60.15 USD 1,805
2024-05-02 2024-05-01 PS Planned sale

Cunningham Everett

Chief Commercial Officer

Officer
136 -0.3%
60.15
USD 8,180
136 -0.3% 60.15 USD 8,180
2024-04-03 2024-04-02 PS Planned sale

Baranick Brian

EVP, GM., Precision Oncology

Officer
924 -6.6%
79.43
USD 73,393
924 -6.6% 79.43 USD 73,393
2024-04-03 2024-04-01 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
2,000 -2.7%
70.00
USD 140,000
2,000 -2.7% 70.00 USD 140,000
2024-04-01 2024-03-28 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
2,000 -2.6%
70.00
USD 140,000
2,000 -2.6% 70.00 USD 140,000
2024-03-04 2024-03-01 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
2,154 -13.1%
59.32
USD 127,775
2,154 -13.1% 59.32 USD 127,775
2024-03-04 2024-03-01 PS Planned sale

Herriott James

General Counsel

Officer
862 -8.6%
59.32
USD 51,134
862 -8.6% 59.32 USD 51,134
2024-03-04 2024-03-01 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
8,271 -0.6%
59.32
USD 490,636
8,271 -0.6% 59.32 USD 490,636
2024-03-04 2024-03-01 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
2,412 -18.1%
59.32
USD 143,080
2,412 -18.1% 59.32 USD 143,080
2024-03-04 2024-03-01 PS Planned sale

Cunningham Everett

Chief Commercial Officer

Officer
2,412 -5.0%
59.32
USD 143,080
2,412 -5.0% 59.32 USD 143,080
2024-03-04 2024-03-01 PS Planned sale

Doyle James Edward

Non-Executive Director
2,000 -3.8%
57.50
USD 115,000
2,000 -3.8% 57.50 USD 115,000
2024-03-04 2024-03-01 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
2,323 -14.1%
59.32
USD 137,800
2,323 -14.1% 59.32 USD 137,800
2024-03-04 2024-03-01 PS Planned sale

LEVANGIE DANIEL J

Non-Executive Director
5,000 -17.9%
57.50
USD 287,500
5,000 -17.9% 57.50 USD 287,500
2024-03-04 2024-03-01 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,724 -2.2%
59.32
USD 102,268
1,724 -2.2% 59.32 USD 102,268
2024-02-28 2024-02-27 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,880 -2.5%
56.89
USD 106,953
1,880 -2.5% 56.89 USD 106,953
2024-02-28 2024-02-27 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
1,879 -13.8%
56.89
USD 106,896
1,879 -13.8% 56.89 USD 106,896
2024-02-28 2024-02-27 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
2,027 -14.8%
56.89
USD 115,316
2,027 -14.8% 56.89 USD 115,316
2024-02-28 2024-02-27 PS Planned sale

Herriott James

General Counsel

Officer
784 -8.8%
56.89
USD 44,602
784 -8.8% 56.89 USD 44,602
2024-02-28 2024-02-27 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
6,263 -0.5%
56.89
USD 356,302
6,263 -0.5% 56.89 USD 356,302
2024-02-28 2024-02-27 PS Planned sale

Cunningham Everett

Chief Commercial Officer

Officer
3,648 -7.8%
56.89
USD 207,535
3,648 -7.8% 56.89 USD 207,535
2024-02-28 2024-02-27 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
2,710 -25.2%
56.89
USD 154,172
2,710 -25.2% 56.89 USD 154,172
2024-02-26 2024-02-23 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,021 -1.4%
59.72
USD 60,974
1,021 -1.4% 59.72 USD 60,974
2024-02-23 2024-02-22 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,013 -1.4%
59.78
USD 60,557
1,013 -1.4% 59.78 USD 60,557
2024-02-23 2024-02-22 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
1,351 -21.1%
59.78
USD 80,763
1,351 -21.1% 59.78 USD 80,763
2024-02-23 2024-02-22 PS Planned sale

COWARD D SCOTT

Non-Executive Director
663 -1.5%
59.78
USD 39,634
663 -1.5% 59.78 USD 39,634
2024-02-23 2024-02-22 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
11,565 -0.9%
59.78
USD 691,356
11,565 -0.9% 59.78 USD 691,356
2024-02-23 2024-02-22 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
1,013 -9.5%
59.78
USD 60,557
1,013 -9.5% 59.78 USD 60,557
2024-02-23 2024-02-22 PS Planned sale

Cunningham Everett

Chief Commercial Officer

Officer
1,350 -3.3%
59.78
USD 80,703
1,350 -3.3% 59.78 USD 80,703
2024-02-23 2024-02-22 PS Planned sale

Herriott James

General Counsel

Officer
291 -3.9%
59.78
USD 17,396
291 -3.9% 59.78 USD 17,396
2024-02-23 2024-02-22 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
1,093 -10.1%
59.78
USD 65,340
1,093 -10.1% 59.78 USD 65,340
2024-02-22 2024-02-21 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
4,975 -0.4%
61.50
USD 305,963
4,975 -0.4% 61.50 USD 305,963
2024-02-22 2024-02-21 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
1,078 -11.1%
61.50
USD 66,297
1,078 -11.1% 61.50 USD 66,297
2024-02-22 2024-02-21 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
895 -9.2%
61.50
USD 55,043
895 -9.2% 61.50 USD 55,043
2024-02-22 2024-02-21 PS Planned sale

COWARD D SCOTT

Non-Executive Director
706 -1.6%
61.50
USD 43,419
706 -1.6% 61.50 USD 43,419
2024-02-22 2024-02-21 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,079 -1.5%
61.50
USD 66,359
1,079 -1.5% 61.50 USD 66,359
2024-02-22 2024-02-21 PS Planned sale

Herriott James

General Counsel

Officer
415 -5.6%
61.50
USD 25,523
415 -5.6% 61.50 USD 25,523
2024-02-22 2024-02-21 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
1,493 -28.7%
61.50
USD 91,820
1,493 -28.7% 61.50 USD 91,820
2024-02-16 2024-02-15 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
965 -1.4%
61.43
USD 59,280
965 -1.4% 61.43 USD 59,280
2024-02-16 2024-02-15 PS Planned sale

COWARD D SCOTT

Non-Executive Director
1,376 -3.2%
61.43
USD 84,528
1,376 -3.2% 61.43 USD 84,528
2024-02-16 2024-02-15 PS Planned sale

Herriott James

General Counsel

Officer
421 -6.1%
61.43
USD 25,862
421 -6.1% 61.43 USD 25,862
2024-02-16 2024-02-15 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
966 -11.4%
61.43
USD 59,341
966 -11.4% 61.43 USD 59,341
2024-02-16 2024-02-15 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
1,888 -47.5%
61.43
USD 115,980
1,888 -47.5% 61.43 USD 115,980
2024-02-16 2024-02-15 PS Planned sale

Conroy Kevin T

President and CEO

Executive Director
14,791 -1.2%
61.43
USD 908,611
14,791 -1.2% 61.43 USD 908,611
2024-01-04 2024-01-02 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
879 -9.9%
73.50
USD 64,607
879 -9.9% 73.50 USD 64,607
2024-01-04 2024-01-02 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
2,000 -2.8%
73.50
USD 147,000
2,000 -2.8% 73.50 USD 147,000
2023-12-18 2023-12-14 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
2,000 -2.7%
70.00
USD 140,000
2,000 -2.7% 70.00 USD 140,000
2023-10-13 2023-10-12 PS Planned sale

Cunningham Everett

Chief Commercial Officer

Officer
13,007 -25.5%
66.49
USD 864,835
13,007 -25.5% 66.49 USD 864,835
2023-09-06 2023-09-01 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
4,500 -5.6%
84.36
USD 379,620
4,500 -5.6% 84.36 USD 379,620
2023-08-23 2023-08-21 PS Planned sale

Elliott Jeffrey Thomas

Chief Financial Officer

Officer
30,210 -100.0%
82.92
USD 2,505,013
30,210 -100.0% 82.92 USD 2,505,013
2023-08-08 2023-08-07 PS Planned sale

Baranick Brian

Gen. Mgr., Precision Oncology

Officer
1,350 -13.2%
85.04
USD 114,804
1,350 -13.2% 85.04 USD 114,804
2023-07-28 2023-07-27 PS Planned sale

Doyle James Edward

Non-Executive Director
2,000 -3.7%
97.42
USD 194,840
2,000 -3.7% 97.42 USD 194,840
2023-07-21 2023-07-19 PS Planned sale

Herriott James

General Counsel

Officer
1,300 -17.9%
100.00
USD 130,000
1,300 -17.9% 100.00 USD 130,000
2023-06-12 2023-06-09 PS Planned sale

Doyle James Edward

Non-Executive Director
1,402 -2.5%
90.51
USD 126,895
1,402 -2.5% 90.51 USD 126,895
2023-06-12 2023-06-09 PS Planned sale

Zanotti Katherine S

Non-Executive Director
3,027 -4.5%
90.51
USD 273,974
3,027 -4.5% 90.51 USD 273,974
2023-06-12 2023-06-08 PS Planned sale

Herriott James

General Counsel

Officer
1,300 -15.2%
90.00
USD 117,000
1,300 -15.2% 90.00 USD 117,000
2023-05-31 2023-05-26 PS Planned sale

Doyle James Edward

Non-Executive Director
2,000 -3.7%
80.62
USD 161,240
2,000 -3.7% 80.62 USD 161,240
2023-05-12 2023-05-10 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
5,000 -43.8%
80.00
USD 400,000
5,000 -43.8% 80.00 USD 400,000
2023-05-12 2023-05-10 PS Planned sale

Herriott James

General Counsel

Officer
1,300 -13.2%
79.85
USD 103,805
1,300 -13.2% 79.85 USD 103,805
2023-05-12 2023-05-10 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
6,087 -7.0%
80.00
USD 486,960
6,087 -7.0% 80.00 USD 486,960
2023-05-03 2023-05-01 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,000 -1.1%
63.78
USD 63,780
1,000 -1.1% 63.78 USD 63,780
2023-04-05 2023-04-03 PS Planned sale

Condella Sarah

EVP, Human Resources

Officer
1,000 -1.1%
67.19
USD 67,190
1,000 -1.1% 67.19 USD 67,190
2023-03-07 2023-03-03 PS Planned sale

ORVILLE JACOB A

General Manager, Screening

Officer
5,000 -30.4%
65.00
USD 325,000
5,000 -30.4% 65.00 USD 325,000
// ... existing code ... // ... rest of the file ...